These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37524213)

  • 41. Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.
    Tan DK; Davis DA; Miller DA; Williams RO; Nokhodchi A
    AAPS PharmSciTech; 2020 Nov; 21(8):312. PubMed ID: 33161479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemically identical but physically different: A comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen.
    Dedroog S; Huygens C; Van den Mooter G
    Eur J Pharm Biopharm; 2019 Feb; 135():1-12. PubMed ID: 30529295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aqueous Dissolution and Dispersion Behavior of Polyvinylpyrrolidone Vinyl Acetate-based Amorphous Solid Dispersion of Ritonavir Prepared by Hot-Melt Extrusion with and without Added Surfactants.
    Siriwannakij N; Heimbach T; Serajuddin ATM
    J Pharm Sci; 2021 Apr; 110(4):1480-1494. PubMed ID: 32827493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
    Tran PHL; Lee BJ; Tran TTD
    Eur J Pharm Biopharm; 2021 Jul; 164():13-19. PubMed ID: 33887388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fenofibrate Solid Dispersion Processed by Hot-Melt Extrusion: Elevated Bioavailability and Its Cell Transport Mechanism.
    Wen T; Niu B; Wu Q; Zhou Y; Pan X; Quan G; Wu C
    Curr Drug Deliv; 2019; 16(6):538-547. PubMed ID: 30674259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
    Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion.
    Forster A; Hempenstall J; Tucker ; Rades T
    Drug Dev Ind Pharm; 2001 Jul; 27(6):549-60. PubMed ID: 11548862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How changes in molecular weight and PDI of a polymer in amorphous solid dispersions impact dissolution performance.
    Auch C; Harms M; Mäder K
    Int J Pharm; 2019 Feb; 556():372-382. PubMed ID: 30553957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Residence time modeling of hot melt extrusion processes.
    Reitz E; Podhaisky H; Ely D; Thommes M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1200-5. PubMed ID: 23933247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Numerical simulation of hot-melt extrusion processes for amorphous solid dispersions using model-based melt viscosity.
    Bochmann ES; Steffens KE; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2018 Mar; 124():34-42. PubMed ID: 29221654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation.
    Alzahrani A; Nyavanandi D; Mandati P; Youssef AAA; Narala S; Bandari S; Repka M
    Int J Pharm; 2022 Aug; 624():121951. PubMed ID: 35753536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In-process rheometry as a PAT tool for hot melt extrusion.
    Kelly AL; Gough T; Isreb M; Dhumal R; Jones JW; Nicholson S; Dennis AB; Paradkar A
    Drug Dev Ind Pharm; 2018 Apr; 44(4):670-676. PubMed ID: 29161918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An investigation into the influence of drug-polymer interactions on the miscibility, processability and structure of polyvinylpyrrolidone-based hot melt extrusion formulations.
    Chan SY; Qi S; Craig DQ
    Int J Pharm; 2015 Dec; 496(1):95-106. PubMed ID: 26428633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study.
    Penumetcha SS; Gutta LN; Dhanala H; Yamili S; Challa S; Rudraraju S; Rudraraju S; Rudraraju V
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1609-20. PubMed ID: 26925514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct Visualization of Drug-Polymer Phase Separation in Ritonavir-Copovidone Amorphous Solid Dispersions Using
    Shi C; Li L; Zhang GGZ; Borchardt TB
    Mol Pharm; 2019 Nov; 16(11):4751-4754. PubMed ID: 31553871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
    Dinunzio JC; Brough C; Hughey JR; Miller DA; Williams RO; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):340-51. PubMed ID: 19818402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Downstream processing from hot-melt extrusion towards tablets: A quality by design approach.
    Grymonpré W; Bostijn N; Herck SV; Verstraete G; Vanhoorne V; Nuhn L; Rombouts P; Beer T; Remon JP; Vervaet C
    Int J Pharm; 2017 Oct; 531(1):235-245. PubMed ID: 28823887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.